Hemodialysis in Methemoglobinemia, a friend or foe? A Case Report
Journal: International Research Journal of Pharmacy and Medical Sciences (IRJPMS) (Vol.7, No. 4)Publication Date: 2024-06-15
Authors : Nur Nadia Mohd Yusof; Noor Shazlini Mustapa; Ahmad Salihin Abdullah; Nor Fadhilah Shafii; Noryani Mohd Samat;
Page : 65-67
Keywords : ;
Abstract
Methemoglobinemia is a potentially fatal illness in which circulating levels of methemoglobin in the blood surpasses the usual physiological level decreases hemoglobin's ability to transport oxygen by shifting the oxygen-dissociation curve to the left, limiting oxygen unloading to tissue and contributing to functional hypoxia.1 Acquired causes are more prevalent as compared to congenital and arises from exposure to chemicals that oxidizes hemoglobin either directly or indirectly.2 Most reports of adult methemoglobinemia are related to medication overdoses from local anesthetics. Hemodialysis is one of the researched causes of methemoglobinemia, even though it is not often reported.3 Removing the causative substances and providing supportive care are the cornerstones of methemoglobinemia treatment. Although it is uncommon these days, physicians should be aware of the risks of methemoglobinemia during prolonged hemodialysis as well as the complications that can result from contamination of the dialysis water
Other Latest Articles
- Development and Characterization of Herbal Gel for Atopic Eczema
- Evaluation of Efficacy of Drained and Drainless Parotid Surgery
- Antioxidant Supplementation and Duration of Antioxidant in Male Infertility – A Systemic Review
- Formulation and Evaluation of Novel Drug Delivery System of Passiflora Incarnata for Antianxiety Activity
- Natural Remedies in the Treatment of Peptic Ulcer: A Review
Last modified: 2024-07-21 20:49:41